L-Tryptophan: Rehabilitation eines erfolgreichen Wirkstoffes zur Therapievon Depressionen und Schlafstörungen

Abstract: L-Tryptophan has been used world-wide to treat depressions and sleep disorders. In 1989, cases of eosinophilia myalgia syndrome (EMS) were found to be related to the intake of preparations of L-Tryptophan, and such preparations had to be withdrawn from the market. Since September 1996, the trading of L-Tryptophan has been reallowed, after it has been shown that EMS resulted from the ingestion of a specific containment rather than from the active substance itself.

Keyword(s): L-Tryptophan

Zurück | Weiter